Privia Health (PRVA) Receivables (2020 - 2026)

Privia Health has reported Receivables for 7 years, with the latest figure at $513.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 32.14% year-over-year to $513.7 million; the trailing twelve-month figure through Mar 2026 stood at $513.7 million (up 32.14% YoY), and the FY2025 full-year result was $400.9 million, up 26.8% from the prior year.
• Receivables for Q1 2026 stood at $513.7 million, up from $400.9 million in the prior quarter.
• The five-year high for Receivables was $513.7 million in Q1 2026, with the low at $166.2 million in Q1 2022.
• Average Receivables over 5 years is $336.8 million, with a median of $346.1 million recorded in 2024.
• Year-over-year, Receivables surged 150.39% in 2022 and climbed 8.74% in 2024.
• Tracing PRVA's Receivables over 5 years: stood at $189.6 million in 2022, then soared by 53.36% to $290.8 million in 2023, then increased by 8.74% to $316.2 million in 2024, then rose by 26.8% to $400.9 million in 2025, then rose by 28.13% to $513.7 million in 2026.
• The last three Receivables figures came in at $513.7 million (Q1 2026), $400.9 million (Q4 2025), and $499.0 million (Q3 2025), per Business Quant data.

Peer Comparison